|
Market Closed -
OTC Markets
10:57:58 2026-06-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.1052 USD | -2.09% |
|
-18.25% | -87.61% |
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-13 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 2.65M 2.28M 2.15M 1.96M 3.68M 251M 3.7M 25.4M 9.89M 128M 9.94M 9.72M 424M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 24.5M 21.14M 19.88M 18.11M 34.06M 2.33B 34.24M 235M 91.48M 1.18B 91.99M 90M 3.92B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.09% | ||
| 1 week | -18.25% | ||
| Current month | -18.25% | ||
| 1 month | -18.25% | ||
| 3 months | +0.29% | ||
| 6 months | -54.04% | ||
| Current year | -87.61% |
| 1 week | 0.11 |  | 0.14 |
| 1 month | 0.11 | | 0.17 |
| Current year | 0.05 | | 1.2 |
| 1 year | 0.05 | | 2.5 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 17.1 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 2025-07-20 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 2025-05-15 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 2016-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 2013-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 2023-03-20 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 2023-03-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/18/26 | Emerging Technology Partners LLC
| Other | Company | 1,097,341 | 7.0830% | |
| 3/18/26 | Panacea Venture
| Other | Company | 4,529,956 | 29.2393% | |
| 3/18/26 | Other | Chief Financial Officer | 75,000 | 0.4841% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.09% | -18.25% | -95.44% | -95.12% | 2.65M | |
| +0.28% | -5.97% | +58.34% | +108.22% | 1,034B | |
| +2.01% | -0.71% | +53.07% | +68.99% | 654B | |
| +1.39% | -2.18% | +23.57% | +75.43% | 459B | |
| +0.78% | -5.05% | +33.47% | +35.73% | 343B | |
| -0.75% | +2.19% | +28.42% | +45.97% | 307B | |
| -0.32% | -2.65% | +0.05% | +11.41% | 251B | |
| +1.92% | -0.93% | +52.28% | +70.67% | 237B | |
| +0.59% | -3.20% | -17.65% | -54.96% | 202B | |
| +2.45% | +0.77% | +32.71% | +95.59% | 186B | |
| Average | +0.75% | -2.59% | +16.88% | +36.19% | 367.16B | |
| Weighted average by Cap. | +1.25% | -3.31% | +38.39% | +66.53% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.62M 23.16M 21.09M 39.67M 2.71B 39.88M 274M 107M 1.38B 107M 105M 4.57B | 20.71M 17.87M 16.81M 15.31M 28.79M 1.97B 28.95M 199M 77.33M 1B 77.76M 76.08M 3.32B |
| Net income | -39.26M -33.86M -31.85M -29.02M -54.57M -3.73B -54.87M -377M -147M -1.9B -147M -144M -6.28B | -48.06M -41.45M -38.99M -35.52M -66.8M -4.56B -67.17M -461M -179M -2.32B -180M -177M -7.69B |
| Net Debt | 6.05M 5.22M 4.91M 4.47M 8.41M 574M 8.46M 58.03M 22.59M 292M 22.71M 22.22M 968M | 21.85M 18.85M 17.73M 16.15M 30.38M 2.07B 30.54M 210M 81.59M 1.06B 82.05M 80.27M 3.5B |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-31 | US$0.1288 | -.--% | 141 |
| 26-08-28 | US$0.1288 | -4.59% | 1,688 |
| 26-08-27 | US$0.1350 | +4.81% | 137 |
| 26-08-25 | US$0.1288 | -7.20% | 125 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASIF Stock
Select your edition
All financial news and data tailored to specific country editions
